Catecholamine and blood pressure regulation by gonadotropin-releasing hormone analogs in amphibians.
Analogs of gonadotropin-releasing hormone (GnRH) occur in the brain, plasma, and sympathoadrenal system of anuran amphibians. The present experiments studied the effects of GnRH and [Trp7, Leu8]-GnRH on plasma catecholamines and cardiovascular function in conscious adult bullfrogs (Rana catesbeiana) and cane toads (Bufo marinus). Both GnRH analogs elicited dose-dependent (0.1-1 nmol.kg-1) increases in arterial norepinephrine, epinephrine, and blood pressure levels when injected intravenously into toads. In bullfrogs, [Trp7, Leu8]-GnRH (1 nmol.kg-1) increased arterial norepinephrine concentration approximately 10-fold without affecting the concentrations of norepinephrine sulfate, norepinephrine glucuronide, epinephrine, epinephrine sulfate, or epinephrine glucuronide. The noradrenergic response of bullfrogs to [Trp7, Leu8]-GnRH was specific to the neurohormone because it could be inhibited by [D-pGlu1, D-Phe2, D-Trp3,6]-GnRH. The sympathomimetic activities of the GnRH analogs did not depend on changes in temperature, which occur seasonally in natural habitats, because similar noradrenergic responses were observed at 4 and 22 degrees C. GnRH and [Trp7, Leu8]-GnRH (0.01-10 nmol.kg-1) did not raise arterial blood pressure in bullfrogs despite their pressor actions in toads. This interspecific difference was remarkable because cardiovascular responses to norepinephrine, angiotensin II, and vasotocin in bullfrogs were similar to those in toads. The parallels between catecholamine and blood pressure responses suggest that epinephrine is the principal mediator of the blood pressure response to native GnRH analogs in toads. In bullfrogs, [Trp7, Leu8]-GnRH mobilizes norepinephrine but not epinephrine, and the noradrenergic effect is insufficient to raise blood pressure. These observations are consistent with a physiological role for native GnRH analogs in the regulation of the sympathoadrenal system in anuran amphibians.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002024:Bufo marinus; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000502:physiology*; D004837:Epinephrine / Q000097:blood / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood / Q000494:pharmacology; D010906:Pituitary Hormone-Releasing Hormones / Q000097:blood / Q000502:physiology*; D011892:Rana catesbeiana; D014668:Vasotocin / Q000494:pharmacology
D002395:Catecholamines; D010906:Pituitary Hormone-Releasing Hormones; D000804:Angiotensin II; D014668:Vasotocin; D009638:Norepinephrine; D004837:Epinephrine